HGF and breast carcinoma: Apart from direct cell-to-cell contact, CAF-secreted hepatocyte growth factor (HGF) binds to c-MET receptor on breast cancer cells, leading to alternative activation of the PI3K/AKT signalling pathway and attenuation of HER2 inhibitor sensitivity in basal-like breast cancer cells52,53.